Home
>
National Drug Code (NDC)
>
ipratropium bromide and albuterol sulfate
ipratropium bromide and albuterol sulfate - 0591-3817-30 - (ipratropium bromide and albuterol sulfate)
Drug Information of ipratropium bromide and albuterol sulfate
| Product NDC: | 0591-3817 |
| Proprietary Name: | ipratropium bromide and albuterol sulfate |
| Non Proprietary Name: | ipratropium bromide and albuterol sulfate |
| Active Ingredient(s): | 2.5; .5 mg/3mL; mg/3mL & nbsp; ipratropium bromide and albuterol sulfate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ipratropium bromide and albuterol sulfate
| Product NDC: | 0591-3817 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202496 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130513 |
Package Information of ipratropium bromide and albuterol sulfate
| Package NDC: | 0591-3817-30 |
| Package Description: | 6 POUCH in 1 CARTON (0591-3817-30) > 5 VIAL in 1 POUCH > 3 mL in 1 VIAL |
NDC Information of ipratropium bromide and albuterol sulfate
| NDC Code | 0591-3817-30 |
| Proprietary Name | ipratropium bromide and albuterol sulfate |
| Package Description | 6 POUCH in 1 CARTON (0591-3817-30) > 5 VIAL in 1 POUCH > 3 mL in 1 VIAL |
| Product NDC | 0591-3817 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ipratropium bromide and albuterol sulfate |
| Dosage Form Name | SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20130513 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE |
| Strength Number | 2.5; .5 |
| Strength Unit | mg/3mL; mg/3mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
